SEC Company Response from Minerva Neurosciences, Inc. (NERV) (CIK 0001598646) (NERV) — Aug 22, 2018
Minerva Neurosciences, Inc. (NERV) (CIK 0001598646)
Date: Aug. 22, 2018 · CIK: 0001598646 · Accession: 0001193125-18-255093
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-226783
Letter
Re: Minerva Neurosciences, Inc.
August 22, 2018
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
Registration Statement on Form S-3 (File No. 333-226783)
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective at 4:00 p.m. Eastern Time on August 24, 2018 or as soon thereafter as is practicable.
Sincerely,
MINERVA NEUROSCIENCES, INC.
Show Raw Text
CORRESP
1
filename1.htm
CORRESP
August 22, 2018
VIA EDGAR
United States
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
Re:
Minerva Neurosciences, Inc.
Registration Statement on Form S-3 (File No. 333-226783)
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned registrant hereby requests that the Securities and Exchange
Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-3 to become effective at 4:00 p.m. Eastern Time on
August 24, 2018 or as soon thereafter as is practicable.
Sincerely,
MINERVA NEUROSCIENCES, INC.
By:
/s/ Devin Smith
Name: Devin Smith
Title: General Counsel
cc:
Marc A. Recht, Esq.
Ryan S. Sansom, Esq.